What the research actually shows
A widely cited analysis summarized by Johns Hopkins Bloomberg School of Public Health found that hearing loss may be the largest modifiable risk factor for dementia among all the risk factors studied. The severity mattered: mild hearing loss was linked to roughly double the dementia risk, moderate loss to about triple, and severe hearing loss to about five times the risk, compared with normal hearing.
The more actionable finding came from a randomized trial published in The Lancet and covered by Johns Hopkins Medicine: among older adults at higher risk for cognitive decline, using hearing aids was associated with nearly a 48% reduction in the rate of cognitive decline over three years, compared with a control group.
That trial has a name: the ACHIEVE study, a multicenter randomized controlled trial sponsored by the National Institute on Aging. It followed 977 older adults ages 70 to 84 with untreated hearing loss, and the 48% figure specifically applied to the subgroup of participants who were already at elevated risk for cognitive decline going into the study. The researchers also note that treating hearing loss with hearing aids carries essentially no health risk of its own, which is part of why it's considered a promising, low-risk intervention worth prioritizing.
Why the link might exist
Researchers don't point to one single mechanism. The leading hypotheses, as described by Johns Hopkins researchers, include:
- Cognitive load — straining to hear and fill in gaps in conversation may divert mental resources away from memory and processing
- Changes in brain structure — reduced auditory input over time may be associated with structural brain changes
- Social withdrawal — people with untreated hearing loss often withdraw from conversation and social settings, and reduced social engagement is separately linked to cognitive decline
None of these are fully settled, and researchers are still working out how much each pathway contributes.
What actually seems to help, based on current evidence
Based on the research above, the most evidence-backed step is straightforward: get hearing loss evaluated and treated, typically with hearing aids, rather than letting it go unaddressed. Beyond that, general habits that support both hearing and brain health include staying socially engaged, protecting your ears from loud noise, and managing cardiovascular health, since blood flow affects both the inner ear and the brain.
Some people also look into nutritional supplements formulated with ingredients traditionally associated with ear and circulatory wellness — like the herbal blend used in Audifort, which combines Maca Root, Grape Seed, Green Tea, and several other botanicals in one daily formula. It's not a treatment for hearing loss or a way to reduce dementia risk, but it's an option some people consider as part of a broader wellness routine — always alongside, not instead of, an actual hearing evaluation.
Quick Check: How's Your Hearing-Brain Connection?
Answer four quick questions to see how your situation lines up with the factors covered above.
A few things worth noting: made in the USA, herbal liquid-drop formula, free of habit-forming substances, backed by a 90-day money-back guarantee.
See the full Audifort ingredient listPurchases are covered by ClickBank's 90-day money-back guarantee.
Disclosure: this article contains an affiliate link. If you make a purchase through it, I may earn a commission at no extra cost to you.
Frequently Asked Questions
Does Audifort prevent dementia or cognitive decline?
No, and we want to be very direct about this. The research linking hearing intervention to lower dementia risk is specifically about treating hearing loss with hearing aids, not about any supplement. Audifort is not intended to diagnose, treat, cure, or prevent any disease, including dementia or cognitive decline.
If I already wear hearing aids, is my risk back to normal?
Research suggests treating hearing loss substantially lowers the added risk, but hearing is only one of many factors that contribute to dementia risk overall. Hearing aid use is a meaningful, modifiable factor — not a guarantee.
Should I see an audiologist even if my hearing loss feels mild?
Based on the research trend, yes — the studies suggest even mild, untreated hearing loss is associated with measurably higher risk, so earlier evaluation rather than waiting until hearing loss is severe appears to be the more evidence-aligned approach.
What is the ACHIEVE study?
ACHIEVE is a randomized controlled trial sponsored by the National Institute on Aging that followed 977 older adults ages 70–84 with untreated hearing loss. It found that using hearing aids was associated with a 48% slower rate of cognitive decline over three years among participants who were already at higher risk for it — the strongest evidence to date that treating hearing loss, specifically, may help protect cognitive function.